RIM
LKFT

RS Investment Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

RS Investment Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-97,182
Closed -$3.96M – 353
2015
Q3 		$3.96M Sell
97,182
-185,158
-66% -$10.7M 0.04% 271
2015
Q2 		$14.5M Buy
+282,340
New +$15M 0.12% 221

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RS Investment Management's LKFT Position: Q4 2015 in Review

RS Investment Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2015, closing a stake of 97,182 shares — an estimated $3.96M sold.

RS Investment Management first reported a position in LKFT in Q2 2015 and held it in 2 quarters. The position peaked at $14.5M in Q2 2015. 44 funds tracked by Wall St. Rank hold LKFT as of Q4 2015.

  • RS Investment Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2015 after selling out during the quarter.
  • RS Investment Management sold 97,182 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2015, an estimated $3.96M.
  • RS Investment Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 2 quarters.
  • RS Investment Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $14.5M in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2015.

Based on RS Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.